Summary
Commonly reported side effects of levomilnacipran include: erectile dysfunction, nausea, and orthostatic hypotension. Other side effects include: constipation, ejaculatory disorder, epididymitis, increased heart rate, palpitations, premature ejaculation, sinus tachycardia, tachycardia, testicular pain, urinary hesitancy, vomiting, delayed ejaculation, ejaculation failure, and hyperhidrosis. Continue reading for a comprehensive list of adverse effects.
Applies to levomilnacipran: oral capsule extended release.
Warning
Oral route (Capsule, Extended Release)
Warning: Suicidal Thoughts and BehaviorsAntidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies. Closely monitor all antidepressant-treated patients for clinical worsening, and for emergence of suicidal thoughts and behaviors. Levomilnacipran is not approved for use in pediatric patients.
Serious side effects of Levomilnacipran
Along with its needed effects, levomilnacipran may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking levomilnacipran:
More common
- Decreased interest in sexual intercourse
- difficult urination
- fast, pounding, or irregular heartbeat or pulse
- inability to have or keep an erection
- loss in sexual ability, desire, drive, or performance
Less common
- Anxiety
- arm, back, or jaw pain
- blurred vision
- burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings
- chest pain, discomfort, heaviness, or tightness
- cloudy urine
- confusion
- decrease in the frequency of urination
- difficulty in passing urine (dribbling)
- difficulty with speaking
- dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
- drooling
- dry mouth
- fainting
- headache
- irritability
- loss of balance control
- muscle trembling, jerking, or stiffness
- nausea
- painful urination
- pounding in the ears
- rapid or irregular heartbeat
- restlessness
- shaking
- shuffling walk
- slow heartbeat
- stiffness of the limbs
- sweating
- trouble breathing
- trouble sleeping
- twisting movements of the body
- uncontrolled movements, especially of the face, neck, and back
- unusual tiredness or weakness
Incidence not known
- Delayed or inability to have an orgasm
Other side effects of Levomilnacipran
Some side effects of levomilnacipran may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common
- Difficulty having a bowel movement (stool)
- increased sweating
- vomiting
Less common
- Bloated or full feeling
- decreased appetite
- dry eyes
- dry skin
- feeling of warmth
- headache, severe and throbbing
- hives or welts, itching, or rash
- passing gas
- red eye
- red face, neck, arms, and occasionally, upper chest
- stomach pain
- sudden sweating
- thirst
- yawning
For Healthcare Professionals
Applies to levomilnacipran: oral capsule extended release.
General
The most commonly reported side effects included nausea, erectile dysfunction, constipation, and hyperhidrosis.[Ref]
Gastrointestinal
Very common (10% or more): Nausea (up to 17%)
Common (1% to 10%): Constipation, vomiting
Frequency not reported: Abdominal pain, flatulence[Ref]
Cardiovascular
Common (1% to 10%): Hot flush, hypertension, hypotension, increased blood pressure, increased heart rate, palpitations, tachycardia
Frequency not reported: Angina pectoris, chest pain, increased diastolic blood pressure, increased orthostatic blood pressure, increased orthostatic heart rate response, increased systolic blood pressure, labile hypertension, orthostatic hypotension, postural orthostatic tachycardia syndrome, sinus tachycardia, supraventricular extrasystoles, ventricular extrasystoles
Postmarketing reports: Takotsubo cardiomyopathy[Ref]
Genitourinary
Erectile dysfunction and urinary hesitation occurred as dose-related events.[Ref]
Common (1% to 10%): Ejaculation disorder, erectile dysfunction, testicular pain, urinary hesitation
Frequency not reported: Ejaculation delayed, ejaculation failure, epididymitis, hematuria, organic erectile dysfunction, pollakiuria, proteinuria, seminal vesiculitis, urinary hesitation, urinary retention[Ref]
Dermatologic
Common (1% to 10%): Hyperhidrosis, rash
Frequency not reported: Dry skin, erythematous rash, generalized rash, macular rash, maculopapular rash, pruritus, urticaria[Ref]
Metabolic
Common (1% to 10%): Decreased appetite
Frequency not reported: Hyponatremia, increased blood cholesterol, thirst[Ref]
Psychiatric
Frequency not reported: Aggression, agitation, anger, bruxism, hypomania activation, mania activation, panic attack, premature ejaculation, psychogenic erectile dysfunction, suicidal behaviors, suicidal thoughts, tension[Ref]
Suicidal thoughts and behaviors more commonly occurred in adolescent and young adults 24 years and younger.[Ref]
Nervous system
Frequency not reported: Extrapyramidal disorder, migraine, paresthesia, postural dizziness, seizure, serotonin syndrome, syncope[Ref]
Ocular
Frequency not reported: Angle closure glaucoma, blurred vision, conjunctival hemorrhage, dry eye[Ref]
Other
Frequency not reported: Discontinuation syndrome[Ref]
Hypersensitivity
Frequency not reported: Hypersensitivity[Ref]
Hematologic
Frequency not reported: Increased bleeding risk[Ref]
Hepatic
Frequency not reported: Abnormal liver function tests[Ref]
Respiratory
Frequency not reported: Yawning[Ref]